Cardiovascular Diseases — Development, Testing, and Validation of A Protocol To Assess Cardiovascular Reactivity in Human Populations
Citation(s)
Anderson NB, McNeilly M, Myers H Autonomic reactivity and hypertension in blacks: a review and proposed model. Ethn Dis. 1991 Spring;1(2):154-70. Review.
Kamarck TW, Jennings JR, Pogue-Geile M, Manuck SB A multidimensional measurement model for cardiovascular reactivity: stability and cross-validation in two adult samples. Health Psychol. 1994 Nov;13(6):471-8.
Kamarck TW, Jennings JR, Stewart CJ, Eddy MJ Reliable responses to a cardiovascular reactivity protocol: a replication study in a biracial female sample. Psychophysiology. 1993 Nov;30(6):627-34.
Kamarck TW Recent developments in the study of cardiovascular reactivity: contributions from psychometric theory and social psychology. Psychophysiology. 1992 Sep;29(5):491-503. Review.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
